Dr. Diana V. Do, MD

Dr. Do practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Do's NPI, 1245270313, was assigned on June 7, 2006. Dr. Do graduated from UCSF School of Medicine in 1999. Dr. Do holds California license C143489.

Dr. Do's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Do's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Do is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Do to 1 more hospital and 2 medical groups, each named with a free account. Dr. Do's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Do practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Do's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Do is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Do's licenses on file in 3 states: California, Nebraska and Maryland.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Do treats.

CMS data shows 2,601 Medicare services from Dr. Do across 10 procedure codes in 2024, for 557 Medicare patients. Medicare paid $146,767 for them.

CMS counts 557 Medicare patients who saw Dr. Do in 2024. The largest group is 65 to 74, with 234 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Do's median patient age at 68, with 57% women.

In 2024, Dr. Do wrote 216 Medicare Part D claims for 77 patients. 63% of them were for generic drugs. CMS names the drug for 157 of them, across 6 drugs with 11 or more claims each, at $2,886 in total drug cost. In 2023, CMS named 210 claims across 7 drugs.

Dr. Do accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of cataract surgery by Dr. Do, more than 54% of the clinicians it reports for that procedure.

Dmand AI links 263 papers to Dr. Do, published from 2006 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Visual Acuity, Tomography, Optical Coherence and Macular Edema. Dr. Do has published most often in Ophthalmology. Dr. Do's most frequent co-authors are Quan Dong Nguyen, MD, Mohammad Ali Sadiq, MD and David S. Boyer, MD.

Dmand AI links Dr. Do to 14 clinical trials, 3 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Macular Degeneration, Edema and Retinal Degeneration. Johns Hopkins University sponsors the most, 7. Open Payments lists research payments to Dr. Do that name 3 trials.

CMS Open Payments shows 318 general payments to Dr. Do from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $136,181. It also lists 43 research payments totaling $67,536 from 2016 to 2025, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Do, most recently CMS Stage 1 EHR in 2013.

Dr. Do graduated from UCSF School of Medicine in 1999.

Dr. Do is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.